◆英語タイトル:Apotex, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C13472
◆発行会社(調査会社):
MarketLine
◆発行日:2019年2月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
MarketLine社の概要はこちらでご確認いただけます。
【レポートの概要】
Apotex, Inc. – Strategy, SWOT and Corporate Finance Report
Summary
Apotex, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Apotex, Inc. (Apotex or ‘the company’) is a privately-owned generic pharmaceutical company. The company produces and sells generic prescription drugs, fine chemicals, disposable plastics and non-prescription and private label medicines to healthcare providers, patients, governments and payers. It produces generic pharmaceuticals that are found in virtually every pharmacy and healthcare facility in Canada and are exported globally. The company operates its business through a network of joint ventures, affiliates, strategic alliances and distributors. Apotex carries out clinical trials at its Clinical Operations Facility in Canada. It has business presence in the Czech Republic, Australia, Mexico, Belgium, the Netherlands, Poland, the UK, Turkey and New Zealand. The company is headquartered in Ontario, Canada.
Scope
- Detailed information on Apotex, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Apotex, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Apotex, Inc. including a breakdown and examination of key business segments
- Intelligence on Apotex, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Apotex, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
- Gain understanding of Apotex, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Apotex, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Apotex, Inc.’s business structure, strategy and prospects.
Table of Contents
Company Snapshot
Table of Contents
Apotex, Inc.: Company Overview
Apotex, Inc.: Overview and Key Facts
Apotex, Inc.: Overview
Apotex, Inc.: Key Facts
Apotex, Inc.: Key Employees
Apotex, Inc.: Key Employee Biographies
Apotex, Inc.: Major Products and Services
Apotex, Inc.: Company History
Apotex, Inc.: Management Statement
Apotex, Inc.: Key Competitors
Apotex, Inc.: Company Analysis
Apotex, Inc.: Business Description
Apotex, Inc.: SWOT Analysis
Apotex, Inc.: SWOT Overview
Apotex, Inc.: Strengths
Apotex, Inc.: Weaknesses
Apotex, Inc.: Opportunities
Apotex, Inc.: Threats
Apotex, Inc.: Corporate Financial Deals Activity
Apotex, Inc.: Financial Deals Overview
Apotex, Inc.: Targets and Partners
Apotex, Inc.: Top Deals 2015 – 2019YTD*
Apotex, Inc.: Advisors
Apotex, Inc.: Top Financial Advisors
Apotex, Inc.: Partnership
Apotex, Inc.: Divestments
Apotex, Inc.: Recent Developments
Apotex, Inc.: News and Events Summary
Apotex, Inc.: Business Expansion
Apotex, Inc.: Business Reorganization
Apotex, Inc.: Contracts
Apotex, Inc.: Corporate Governance
Apotex, Inc.: Financial Performance
Apotex, Inc.: Regulatory and Legal Events
Appendix
Contact Us
Methodology
About MarketLine
List of Tables
Table 1: Apotex, Inc.: Key Facts
Table 2: Apotex, Inc.: Key Employees
Table 3: Apotex, Inc.: Company History
Table 4: Apotex, Inc.: Key Competitors
Table 5: Apotex, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Apotex, Inc.: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 7: Apotex, Inc.: Targets and Partners
Table 8: Apotex, Inc.: Top Deals 2015 - 2019YTD*
Table 9: Apotex, Inc.: Financial Advisor Ranking by Value (US$m)
Table 10: Apotex, Inc.: Partnership Volume and Value Trend (2015 - YTD*2019)
Table 11: Apotex, Inc.: Partnership Trend by Deal Type (2015 - YTD*2019)
Table 12: Apotex, Inc.: Divestments Volume and Value Trend (2015 - YTD*2019)
Table 13: Apotex, Inc.: News and Events Summary
Table 14: Apotex, Inc.: Business Expansion
Table 15: Apotex, Inc.: Business Reorganization
Table 16: Apotex, Inc.: Contracts
Table 17: Apotex, Inc.: Corporate Governance
Table 18: Apotex, Inc.: Financial Performance
Table 19: Apotex, Inc.: Regulatory and Legal Events
List of Figures
Figure 1: Apotex, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Apotex, Inc.: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Figure 3: Apotex, Inc.: Partnership Volume and Value Trend (2015 - YTD*2019)
Figure 4: Apotex, Inc.: Partnership Trend by Deal Type (2015 - YTD*2019)
Figure 5: Apotex, Inc.: Divestments Volume and Value Trend (2015 - YTD*2019)